Diabetes decisions — 2025

The Board remanded all claims for service connection due to missing service treatment records and VA's failure to assist the veteran.

The veteran's service connection for non-Hodgkin's lymphoma, prostate cancer, and diabetes mellitus is granted under the PACT Act due to presumed exposure to herbicide agents during service at a Royal Thai Airforce Base.

The appeal for service connection of obstructive sleep apnea (OSA) secondary to diabetes mellitus, type II is remanded. The Board needs more information from a medical examiner.

The appeal for service connection of diabetes mellitus was dismissed because the issue has been resolved and there is no remaining controversy.

The veteran's claims for earlier effective dates and higher ratings were mostly denied, but the issue of an initial rating in excess of 60 percent for coronary artery disease status post coronary artery bypass surgery was remanded.

The Board denied service connection for diabetes mellitus type 2 and hypertension on bases other than the PACT Act because the evidence did not show a relationship between these conditions and the veteran's service.

The Board granted service connection for obstructive sleep apnea as secondary to diabetes mellitus. The Veteran's obesity served as an intermediate step between the two conditions.

The Board denied earlier effective dates for service connection of coronary artery disease and diabetes mellitus. It granted a 20 percent rating for diabetic peripheral neuropathy before August 14, 2020, but denied higher ratings. The issue of service connection for hypertension was remanded.

The veteran's claim for a higher rating for diabetes mellitus type II was dismissed because the veteran withdrew the appeal. The claims for hypertension and bilateral hearing loss were denied as the criteria for a compensable disability rating were not met.

The appeal is remanded to correct errors in the duty-to-assist process. The Board will consider new evidence on whether the Veteran's service-connected diabetes contributed to his death.

The veteran's effective date for increased ratings of left eye retinopathy, diabetes mellitus, and right upper extremity neuropathy was granted as of October 28, 2017.

Service connection for diabetes was denied. TDIU was denied before March 21, 2022, but granted from March 22, 2022.

The Board remanded the veteran's claims for service connection of type 2 diabetes mellitus, hypertension, prostate disability, and peripheral neuropathy, as well as a claim for TDIU. The decision was based on inadequate medical opinions and non-compliance with prior remands.

The veteran's service connection for frostbite residuals in both feet was granted, but the claim for diabetes mellitus was denied.

The veteran's claims for service connection for autoimmune and cardiovascular disabilities were denied. The claims for lumbar spine, radiculopathy, and bilateral knee disabilities were remanded.

The veteran is granted special monthly compensation (SMC) based on aid and attendance due to service-connected disabilities.

The Board denied service connection for PTSD and an earlier effective date for lumbosacral strain. It remanded decisions on other conditions.

The veteran's claim for special monthly compensation (SMC) based on the need for regular aid and attendance was granted. The claim for service connection for Zenker's diverticulum was remanded due to new evidence.

The Board granted service connection for diabetes mellitus type II as secondary to the veteran's service-connected major depressive disorder.

The appeal for service connection of diabetes was dismissed because the initial decision was deferred and not final.